Showing results (171-180 of 254) with videos related to

Sort By:
Pageof 26
The American Journal of Medicine|March 26, 2011
The consequences of requesting "dispense as written"William H Shrank, Joshua N Liberman, Michael A Fischer, et al.
Biochemistry|May 24, 2013
Rational optimization of drug-target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme-product complexAndrew Chang, Johannes Schiebel, Weixuan Yu, et al.
European Urology Oncology|May 29, 2019
Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder CancerYingqi Wang, Andrew Chang, Wei Phin Tan, et al.
Cancer Discovery|January 11, 2020
Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor MicroenvironmentPeiwen Chen, Wen-Hao Hsu, Andrew Chang, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 2, 2024
Neuromodulation for the treatment of Prader-Willi syndrome - A systematic reviewLiming Qiu, Andrew Chang, Ruoyu Ma, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
A Machine Learning-Enabled Venom Peptide Platform for Rapid Drug DiscoveryFei Cai, Lijuan Zhou, Bryce Delgado, et al.
Psychological Trauma : Theory, Research, Practice and Policy|August 27, 2024
Clinical benefits of self-guided mindfulness coach mobile app use for veterans with posttraumatic stress disorder: A pilot randomized control trialJoseph Wielgosz, Robyn D Walser, Eric Kuhn, et al.
Chemical Science|August 23, 2016
Correlating Drug-Target Kinetics and In vivo Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP ReductaseFereidoon Daryaee, Andrew Chang, Johannes Schiebel, et al.
CJEM|June 7, 2022
Out-of-hospital management of unresponsive, apneic, witnessed opioid overdoses: a case series from a supervised consumption siteAdrianna Rowe, Andrew Chang, Emily Lostchuck, et al.
Ophthalmology. Retina|June 24, 2024
Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway TrialJared S Nielsen, Andrew Chang, Nancy M Holekamp, et al.
Pageof 26